We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovative Biodegradable Alloy Advances Bone Implants

By HospiMedica International staff writers
Posted on 16 Jul 2020
A new bioresorbable alloy based on magnesium, gallium, and zinc can be used to make temporary implants for the treatment of fractures, osteoporosis, and myeloma. More...


Developed at the Russian National University of Science and Technology (NUST-MISiS; Moscow, Russia), Monash University (Melbourne, Australia), and other institutions, the new bioresorbable alloy takes advantage of the efficacy of gallium in inhibiting bone resorption, osteoporosis, Paget's disease, and other illnesses. The alloy is intended for use in the manufacture of temporary implants for the treatment of fractures, and the restoration of surgically removed bone due to pathologies.

A severe plastic deformation technique of equal channel angular pressing (ECAP) provides the alloy with favorable mechanical properties and a low rate of degradation and biocorrosion, in contrast to alloys that are based largely on magnesium. As result, it does not undergo a rapid decomposition process in the environment of the human body, and retains its supporting functions throughout the healing process. The study was published on May 12, 2020, in the Journal of Magnesium and Alloys.

“Gallium is known as an ‘inhibitor’ of bone resorption, it is effective in treating disorders associated with accelerated bone loss,” said Alexander Komissarov, PhD, head of the Hybrid Nanostructured Materials Laboratory at NUST MISIS. “Gallium is also involved in biochemical regeneration processes, increasing the thickness, strength, and mineral content of the bone. Finally, it has an antibacterial effect, which is especially important in implantology.”

Gallium is predominantly used in electronics. And although gallium it has no natural function in biology, gallium ions interact with processes in the body in a manner similar to iron (Fe). The body therefore handles Gallium as though it were Fe3+, and the ion is bound in areas of inflammation, such as infection, and in areas of rapid cell division. It is also used in nuclear medicine imaging radiopharmaceutical agents (Gallium scan), such as the radioactive isotope 67Ga.

Related Links:
Russian National University of Science and Technology
Monash University



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.